Stability of β-lactam antibiotics in bacterial growth media.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
19
05
2020
accepted:
30
06
2020
entrez:
21
7
2020
pubmed:
21
7
2020
medline:
2
10
2020
Statut:
epublish
Résumé
Laboratory assays such as MIC tests assume that antibiotic molecules are stable in the chosen growth medium-but rapid degradation has been observed for antibiotics including β-lactams under some conditions in aqueous solution. Degradation rates in bacterial growth medium are less well known. Here, we develop a 'delay time bioassay' that provides a simple way to estimate antibiotic stability in bacterial growth media, using only a plate reader and without the need to measure the antibiotic concentration directly. We use the bioassay to measure degradation half-lives of the β-lactam antibiotics mecillinam, aztreonam and cefotaxime in widely-used bacterial growth media based on MOPS and Luria-Bertani (LB) broth. We find that mecillinam degradation can occur rapidly, with a half-life as short as 2 hours in MOPS medium at 37°C and pH 7.4, and 4-5 hours in LB, but that adjusting the pH and temperature can increase its stability to a half-life around 6 hours without excessively perturbing growth. Aztreonam and cefotaxime were found to have half-lives longer than 6 hours in MOPS medium at 37°C and pH 7.4, but still shorter than the timescale of a typical minimum inhibitory concentration (MIC) assay. Taken together, our results suggest that care is needed in interpreting MIC tests and other laboratory growth assays for β-lactam antibiotics, since there may be significant degradation of the antibiotic during the assay.
Identifiants
pubmed: 32687523
doi: 10.1371/journal.pone.0236198
pii: PONE-D-20-14950
pmc: PMC7371157
doi:
Substances chimiques
Anti-Bacterial Agents
0
Culture Media
0
Cefotaxime
N2GI8B1GK7
Amdinocillin
V10579P3QZ
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0236198Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Mol Cell. 2011 May 20;42(4):413-25
pubmed: 21596308
J Infect Dis. 1982 Jan;145(1):110-7
pubmed: 6459389
J Pharm Sci. 1983 Jan;72(1):59-63
pubmed: 6298400
Ann N Y Acad Sci. 2013 Jan;1277:8-28
pubmed: 23215820
Cell. 2009 Nov 13;139(4):707-18
pubmed: 19914165
J Clin Pathol. 1973 Jan;26(1):1-6
pubmed: 4348402
J Antimicrob Chemother. 2016 May;71(5):1264-9
pubmed: 26832758
Crit Rev Anal Chem. 2017 Jul 4;47(4):359-371
pubmed: 28287269
Chem Pharm Bull (Tokyo). 1992 Dec;40(12):3222-7
pubmed: 1294324
Antimicrob Agents Chemother. 1980 Mar;17(3):397-401
pubmed: 6252829
Antimicrob Agents Chemother. 1975 Sep;8(3):266-70
pubmed: 241287
J Antibiot (Tokyo). 2016 Nov;69(11):791-797
pubmed: 26956793
J Bacteriol. 1974 Sep;119(3):736-47
pubmed: 4604283
Nucleic Acids Res. 2007;35(4):1169-77
pubmed: 17264119
Nature. 2016 Aug 11;536(7615):165-70
pubmed: 27479321
Appl Environ Microbiol. 1997 Jun;63(6):2355-60
pubmed: 9172355
J R Soc Interface. 2015 Sep 6;12(110):0608
pubmed: 26333814
J Pharm Sci. 1971 Apr;60(4):503-32
pubmed: 4336386
J Antimicrob Chemother. 1977 Jul;3 Suppl B:13-9
pubmed: 330482
PLoS One. 2014 Sep 05;9(9):e106967
pubmed: 25191847
Spectrochim Acta A Mol Biomol Spectrosc. 2015 Apr 5;140:474-8
pubmed: 25638429
Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3463-E3470
pubmed: 29581252
Antimicrob Agents Chemother. 2014 Aug;58(8):4573-82
pubmed: 24867991
Mol Gen Genet. 1976 Sep 23;147(3):251-62
pubmed: 787762
Nat Genet. 2011 Dec 18;44(1):101-5
pubmed: 22179135
Biosens Bioelectron. 2014 Aug 15;58:165-71
pubmed: 24632462
Mol Syst Biol. 2015 Jul 29;11(7):822
pubmed: 26227664
J Antimicrob Chemother. 2001 Jul;48 Suppl 1:5-16
pubmed: 11420333
Mol Syst Biol. 2015 Apr 29;11(4):807
pubmed: 25924924
Biopolymers. 1971;10(8):1377-418
pubmed: 5094578
Pharm Weekbl Sci. 1987 Feb 20;9(1):1-23
pubmed: 3550684
J Bacteriol. 1986 Oct;168(1):199-206
pubmed: 3531167
Antimicrob Agents Chemother. 1976 May;9(5):793-9
pubmed: 949176
Science. 2002 Aug 16;297(5584):1183-6
pubmed: 12183631
Nat Ecol Evol. 2017 Jan 30;1(3):50
pubmed: 28812723
PLoS One. 2012;7(4):e35452
pubmed: 22536386
J Pharm Sci. 1979 Oct;68(10):1207-15
pubmed: 41925
Trends Biotechnol. 2011 Apr;29(4):167-73
pubmed: 21232809
Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):16169-74
pubmed: 24046367
J Antimicrob Chemother. 2004 Apr;53(4):675-7
pubmed: 15014060
Bone Joint Res. 2017 May;6(5):296-306
pubmed: 28515059
Biochemistry. 2014 Jul 1;53(25):4113-21
pubmed: 24901294
Cell Mol Life Sci. 2016 Dec;73(23):4471-4492
pubmed: 27392605
PLoS Biol. 2015 Nov 18;13(11):e1002299
pubmed: 26581035
Antimicrob Agents Chemother. 2002 Aug;46(8):2327-32
pubmed: 12121900
Antimicrob Agents Chemother. 2015 May;59(5):2785-90
pubmed: 25733506
J Antibiot (Tokyo). 2009 Jan;62(1):5-16
pubmed: 19132062